Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKesson
Covington
Argus Health
Harvard Business School
QuintilesIMS
Daiichi Sankyo
Farmers Insurance
Baxter

Generated: February 22, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER

« Back to Dashboard

Clinical Trials for Vancomycin Hydrochloride In Plastic Container

Trial ID Title Status Sponsor Phase Summary
NCT00003805 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed European Organisation for Research and Treatment of Cancer - EORTC Phase 3 RATIONALE: Antibiotic therapy may prevent the development of infection in patients with hematologic cancer and the persistent fever caused by a low white blood cell count. It is not yet known which regimen of antibiotics is most effective in preventing infection in these patients. PURPOSE: Randomized phase III trial to study the effectiveness of piperacillin-tazobactam with or without vancomycin in reducing fever in patients who have leukemia, lymphoma, or Hodgkin's disease.
NCT00034294 A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea Completed Genzyme, a Sanofi Company Phase 2 Approximately 300 patients will be entered into this study taking place throughout the United States, Canada and the United Kingdom. This study aims to determine if an investigational drug is safe and effective for treating the symptoms of C. difficile-associated diarrhea and lowering the risk of repeat episodes of diarrhea. The investigational drug will be evaluated in comparison to current standard antibiotic treatment, so all patients will receive active medication. All study-related care is provided including doctor visits, physical exams, laboratory tests and study medication. Total length of participation is approximately 10 weeks.
NCT00035425 Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection Completed Pfizer Phase 3 This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria).
NCT00035854 New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) Completed Pfizer Phase 3 This study will treat pediatric patients who have infections that are due to a specific bacteria (Vancomycin-Resistant Enterococcus)
NCT00037050 Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria Completed Pfizer Phase 3 This study will treat patients who have a short term central catheter that is thought to be infected with a specific bacteria (gram positive bacteria)
NCT00057369 Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections Unknown status Vicuron Pharmaceuticals Phase 2 This is a study to evaluate a new medication dosed once a week in the treatment of bacterial infections in the blood from intravenous catheters (CR-BSI). The primary objective is to evaluate the efficacy and safety of dalbavancin in the treatment of adults with CR-BSI relative to a standard of care treatment, vancomycin.
NCT00079976 Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA) Completed Wyeth is now a wholly owned subsidiary of Pfizer Phase 3 To evaluate the safety and efficacy of tigecycline in the treatment of selected serious infections caused by VRE. The primary efficacy endpoint will be the clinical response for all subjects.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Vancomycin Hydrochloride In Plastic Container

Condition Name

Condition Name for Vancomycin Hydrochloride In Plastic Container
Intervention Trials
Clostridium Difficile Infection 31
Infection 15
Clostridium Difficile 14
Bacteremia 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Vancomycin Hydrochloride In Plastic Container
Intervention Trials
Infection 113
Communicable Diseases 94
Staphylococcal Infections 37
Pneumonia 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Vancomycin Hydrochloride In Plastic Container

Trials by Country

Trials by Country for Vancomycin Hydrochloride In Plastic Container
Location Trials
United States 807
Canada 57
Spain 35
United Kingdom 32
Brazil 27
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Vancomycin Hydrochloride In Plastic Container
Location Trials
California 50
Texas 47
Ohio 45
Florida 37
Michigan 37
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Vancomycin Hydrochloride In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Vancomycin Hydrochloride In Plastic Container
Clinical Trial Phase Trials
Phase 4 89
Phase 3 76
Phase 2/Phase 3 11
[disabled in preview] 144
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Vancomycin Hydrochloride In Plastic Container
Clinical Trial Phase Trials
Completed 120
Recruiting 81
Not yet recruiting 40
[disabled in preview] 73
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Vancomycin Hydrochloride In Plastic Container

Sponsor Name

Sponsor Name for Vancomycin Hydrochloride In Plastic Container
Sponsor Trials
Cubist Pharmaceuticals LLC 23
Pfizer 15
Forest Laboratories 11
[disabled in preview] 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Vancomycin Hydrochloride In Plastic Container
Sponsor Trials
Other 346
Industry 136
U.S. Fed 10
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Farmers Insurance
Federal Trade Commission
Mallinckrodt
Medtronic
QuintilesIMS
AstraZeneca
US Army
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.